DD256701A5 - Verfahren zur herstellung neuer pyrimido (5,4-b) (1,4)-oxozin-derivate - Google Patents

Verfahren zur herstellung neuer pyrimido (5,4-b) (1,4)-oxozin-derivate Download PDF

Info

Publication number
DD256701A5
DD256701A5 DD86298832A DD29883286A DD256701A5 DD 256701 A5 DD256701 A5 DD 256701A5 DD 86298832 A DD86298832 A DD 86298832A DD 29883286 A DD29883286 A DD 29883286A DD 256701 A5 DD256701 A5 DD 256701A5
Authority
DD
German Democratic Republic
Prior art keywords
group
methyl
pyrimido
dihydro
general formula
Prior art date
Application number
DD86298832A
Other languages
German (de)
English (en)
Inventor
Kasztreiner
Rabloczky
Makk
Cseh
Kuhar
Diesler
Jaszlits
Sebestyen
Wellmann
Tegdes
Sarossy
Matyus
Varro
Szam
Vegvari
Original Assignee
�������@���������@��@����������@��������@�����@��Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �������@���������@��@����������@��������@�����@��Kk�� filed Critical �������@���������@��@����������@��������@�����@��Kk��
Publication of DD256701A5 publication Critical patent/DD256701A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DD86298832A 1985-12-30 1986-12-30 Verfahren zur herstellung neuer pyrimido (5,4-b) (1,4)-oxozin-derivate DD256701A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU855042A HU195822B (en) 1985-12-30 1985-12-30 Process for producing new pyrimido/5,4-b//1,h/oxazine derivatives

Publications (1)

Publication Number Publication Date
DD256701A5 true DD256701A5 (de) 1988-05-18

Family

ID=10969567

Family Applications (1)

Application Number Title Priority Date Filing Date
DD86298832A DD256701A5 (de) 1985-12-30 1986-12-30 Verfahren zur herstellung neuer pyrimido (5,4-b) (1,4)-oxozin-derivate

Country Status (20)

Country Link
US (1) US4748175A (hu)
EP (1) EP0228094B1 (hu)
JP (1) JPS62228082A (hu)
CN (1) CN1021734C (hu)
AT (1) ATE66232T1 (hu)
AU (1) AU586380B2 (hu)
CA (1) CA1287052C (hu)
CS (1) CS268822B2 (hu)
DD (1) DD256701A5 (hu)
DE (1) DE3680893D1 (hu)
DK (1) DK630186A (hu)
ES (1) ES2003643A6 (hu)
FI (1) FI82469C (hu)
GR (1) GR862962B (hu)
HU (1) HU195822B (hu)
IL (1) IL81117A (hu)
NO (1) NO170935C (hu)
NZ (1) NZ218795A (hu)
SU (2) SU1567122A3 (hu)
YU (1) YU46039B (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1331178C (en) * 1988-02-05 1994-08-02 James J. Wade Triazolo ¬1,5-c| pyrimido ¬1,4| azines as bronchodilators
GB2359551A (en) * 2000-02-23 2001-08-29 Astrazeneca Uk Ltd Pharmaceutically active pyrimidine derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215216A (en) * 1979-04-18 1980-07-29 American Home Products Corporation 7,8-Dihydro-2,5,8-trisubstituted-7-oxo-pyrido[2,3-d]pyrimidine-6-carboxylic acid derivatives

Also Published As

Publication number Publication date
FI82469B (fi) 1990-11-30
CA1287052C (en) 1991-07-30
ATE66232T1 (de) 1991-08-15
EP0228094A2 (de) 1987-07-08
CN86108914A (zh) 1987-09-30
EP0228094A3 (en) 1988-10-12
FI865344A (fi) 1987-07-01
EP0228094B1 (de) 1991-08-14
DE3680893D1 (de) 1991-09-19
FI865344A0 (fi) 1986-12-30
YU227986A (en) 1988-02-29
CS1026286A2 (en) 1989-08-14
AU586380B2 (en) 1989-07-06
US4748175A (en) 1988-05-31
IL81117A0 (en) 1987-03-31
NO170935B (no) 1992-09-21
GR862962B (en) 1987-05-05
HUT44032A (en) 1988-01-28
ES2003643A6 (es) 1988-11-01
DK630186D0 (da) 1986-12-29
SU1567122A3 (ru) 1990-05-23
JPS62228082A (ja) 1987-10-06
AU6704386A (en) 1987-07-02
CN1021734C (zh) 1993-08-04
HU195822B (en) 1988-07-28
YU46039B (sh) 1992-12-21
NO170935C (no) 1992-12-30
NO865347L (no) 1987-07-01
SU1567123A3 (ru) 1990-05-23
NZ218795A (hu) 1989-02-24
DK630186A (da) 1987-07-01
IL81117A (en) 1990-07-12
CS268822B2 (en) 1990-04-11
FI82469C (fi) 1991-03-11

Similar Documents

Publication Publication Date Title
EP1040101B1 (de) Substituierte 2-aryl-4-amino-chinazoline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE69824632T2 (de) Purinderivate und medikamente, welche dieselben als aktiven bestandteil enthalten
DE69724108T2 (de) Isochinolinderivate und arzneimittel
DE69107215T2 (de) (2-imidazolin-2-ylamino)chinoxalinderivate und methoden in ihrer anwendung.
DE19836697A1 (de) Substituierte 4-Amino-2-aryl-pyrimidine, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
EP0366061A1 (de) Die Verwendung von 4H-1-Benzopyran-4-on-Derivaten, neue 4H-1-Benzopyran-4-on-Derivate und diese enthaltende Arzneimittel
DE10323345A1 (de) Neue Pyridopyrazine und deren Verwendung als Kinase-Inhibitoren
DD139855A5 (de) Verfahren zur herstellung von xanthinderivaten
EP1425283A1 (de) Neue 4-aminofuropyrimidine und ihre verwendung
DE68925270T2 (de) Pyrrolo[3,2-e]pyrazolo[1,5-a]pyrimidinderivate und diese enthaltende Arzneimittel
DE102004057645A1 (de) Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen
DE69811492T2 (de) Benzonaphthyridine
DD262023A5 (de) Verfahren zur herstellung von dihydropyridinen
DE3717080C2 (de) 1-(Hydroxystyryl)-5H-2,3-benzodiazepinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
EP1176144A1 (de) Neue N-Triazolylmethyl-Piperazinderivate als Neurokininrezeptor-Antagonisten
DE2804519C2 (hu)
EP1678130B1 (de) Amidomethyl-substituierte 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro- 2h-chromen-6-yl-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4661484A (en) Pyridazinone derivatives and salts thereof as cardiac stimulants
DE60202969T2 (de) Substituierte alkylaminopyridazinonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
DD256701A5 (de) Verfahren zur herstellung neuer pyrimido (5,4-b) (1,4)-oxozin-derivate
DE69016592T2 (de) 4-Amidino-Chroman und 4-Amidino-Pyrano(3,2-c)pyridinderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
DE2322313A1 (de) Pyrazolderivate und verfahren zu ihrer herstellung
CH637391A5 (de) Therapeutisch wirksame 3-(1-piperazinyl)-1,2,4-benzotriazine und ihre n-oxide.
EP0075165B1 (de) 9,10-Substituierte 2-Mesitylimino-3-alkyl-3,4,6,7-tetrahydro-2H-pyrimido(6,1-a)isochinolin-4-one, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE69229501T2 (de) Benzopyranderivat und dieses als aktives bestandteil enthaltendes antiallergikum

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee